• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫疗法与化疗联合使用的原理。

Rationale for combining immunotherapy with chemotherapy.

作者信息

Dalgleish Angus G

出版信息

Immunotherapy. 2015;7(3):309-16. doi: 10.2217/imt.14.111.

DOI:10.2217/imt.14.111
PMID:25804482
Abstract

Immunotherapy has usually been considered as an alternative to more traditional modalities. Moreover, it has previously been felt that chemotherapy is inherently immunosuppressive and not suitable for combining with immunotherapy. In this review, the concept of combining different modalities that result in cell death, such as radiotherapy and chemotherapy, with immunotherapy is explored. Tumors actively cause immune suppression which can be reversed by their removal but when this is not possible, enhancing the immune response with nonspecific immune stimulation can enhance the response to other modalities, such as radiotherapy and chemotherapy. Additionally, several chemotherapy agents at low doses selectively inhibit regulatory and suppressor cells.

摘要

免疫疗法通常被视为更传统治疗方式的替代方法。此外,过去人们认为化疗本质上具有免疫抑制作用,不适合与免疫疗法联合使用。在本综述中,探讨了将放疗和化疗等导致细胞死亡的不同治疗方式与免疫疗法相结合的概念。肿瘤会主动引起免疫抑制,切除肿瘤可逆转这种抑制,但在无法切除肿瘤时,通过非特异性免疫刺激增强免疫反应可提高对放疗和化疗等其他治疗方式的反应。此外,低剂量的几种化疗药物可选择性抑制调节性细胞和抑制性细胞。

相似文献

1
Rationale for combining immunotherapy with chemotherapy.免疫疗法与化疗联合使用的原理。
Immunotherapy. 2015;7(3):309-16. doi: 10.2217/imt.14.111.
2
Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future.探索免疫疗法和放射疗法在癌症治疗中益处的临床试验:回顾过去,展望未来。
Curr Probl Cancer. 2016 Jan-Feb;40(1):38-67. doi: 10.1016/j.currproblcancer.2015.10.002. Epub 2015 Dec 4.
3
Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.放疗与免疫检查点抑制剂治疗:增敏作用及协同作用的潜在机制。
Lancet Oncol. 2015 Oct;16(13):e498-509. doi: 10.1016/S1470-2045(15)00007-8.
4
Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges.放射治疗联合免疫检查点阻断免疫疗法:成就与挑战。
Cancer Lett. 2015 Aug 28;365(1):23-9. doi: 10.1016/j.canlet.2015.05.012. Epub 2015 May 14.
5
Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?化疗是否通过优先损害调节性T细胞来增强抗肿瘤免疫疗法?
Med Hypotheses. 2008 Nov;71(5):802-4. doi: 10.1016/j.mehy.2008.06.022. Epub 2008 Aug 8.
6
How immunotherapy can enhance the response to other modalities and improve outcome and quality of life.免疫疗法如何增强对其他治疗方式的反应并改善治疗效果和生活质量。
J BUON. 2009 Sep;14 Suppl 1:S103-9.
7
The interplay of immunotherapy and chemotherapy: harnessing potential synergies.免疫疗法和化疗的相互作用:利用潜在的协同作用。
Cancer Immunol Res. 2015 May;3(5):436-43. doi: 10.1158/2326-6066.CIR-15-0064.
8
Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.放射疗法与免疫疗法:通过协同作用改善癌症治疗
Prog Tumor Res. 2015;42:67-78. doi: 10.1159/000437185. Epub 2015 Sep 4.
9
Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells.癌症免疫疗法与可阻断免疫抑制细胞的临床可用药物的联合使用。
Immunol Invest. 2014;43(6):517-34. doi: 10.3109/08820139.2013.857352. Epub 2013 Dec 2.
10
Combination approaches to immunotherapy: the radiotherapy example.免疫疗法的联合方法:放射治疗范例。
Immunotherapy. 2009 Nov;1(6):1025-37. doi: 10.2217/imt.09.64.

引用本文的文献

1
Comparative efficacy of immune checkpoint inhibitors combined with chemotherapy in patients with advanced driver-gene negative non-small cell lung cancer: A systematic review and network meta-analysis.免疫检查点抑制剂联合化疗治疗晚期驱动基因阴性非小细胞肺癌患者的疗效比较:一项系统评价和网状Meta分析
Heliyon. 2024 May 7;10(10):e30809. doi: 10.1016/j.heliyon.2024.e30809. eCollection 2024 May 30.
2
Emerging Therapies in Penile Cancer.阴茎癌的新兴治疗方法
Front Oncol. 2022 Jun 21;12:910335. doi: 10.3389/fonc.2022.910335. eCollection 2022.
3
Comprehensive Analysis of 5-Methylcytosine (mC) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy.
胰腺导管腺癌中5-甲基胞嘧啶(mC)调控因子与免疫微环境的综合分析以辅助免疫治疗
Front Oncol. 2022 Mar 31;12:851766. doi: 10.3389/fonc.2022.851766. eCollection 2022.
4
Cancer Vaccines: Antigen Selection Strategy.癌症疫苗:抗原选择策略
Vaccines (Basel). 2021 Jan 25;9(2):85. doi: 10.3390/vaccines9020085.
5
Treatment effects of cumulative cisplatin dose during radiotherapy following induction chemotherapy in nasopharyngeal carcinoma: propensity score analyses.诱导化疗后鼻咽癌放疗期间顺铂累积剂量的治疗效果:倾向评分分析
Ther Adv Med Oncol. 2020 Jun 25;12:1758835920937424. doi: 10.1177/1758835920937424. eCollection 2020.
6
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View.NF-κB 能否被视为肿瘤疾病的有效药物靶点?我们的观点。
Int J Mol Sci. 2020 Apr 27;21(9):3070. doi: 10.3390/ijms21093070.
7
Metronomic paclitaxel improves the efficacy of PD-1 monoclonal antibodies in breast cancer by transforming the tumor immune microenvironment.节拍性紫杉醇通过改变肿瘤免疫微环境提高PD-1单克隆抗体在乳腺癌中的疗效。
Am J Transl Res. 2020 Feb 15;12(2):519-530. eCollection 2020.
8
Temozolomide promotes immune escape of GBM cells via upregulating PD-L1.替莫唑胺通过上调程序性死亡受体配体1(PD-L1)促进胶质母细胞瘤(GBM)细胞的免疫逃逸。
Am J Cancer Res. 2019 Jun 1;9(6):1161-1171. eCollection 2019.
9
Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer.利用固有免疫系统和局部免疫微环境治疗结直肠癌。
Br J Cancer. 2019 Apr;120(9):871-882. doi: 10.1038/s41416-019-0441-6. Epub 2019 Apr 2.
10
Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects.用于癌症免疫治疗的癌-睾丸抗原肽疫苗:进展与展望
Transl Oncol. 2019 May;12(5):733-738. doi: 10.1016/j.tranon.2019.02.008. Epub 2019 Mar 14.